Rani Therapeutics 2026 annual meeting vote results
Rani Therapeutics Holdings, Inc. held its annual stockholder meeting on May 28, 2026.
Rhea-AI Filing Summary
Rani Therapeutics Holdings, Inc. held its annual stockholder meeting on May 28, 2026. Stockholders voted together as a single class, with one vote per share of both Class A and Class B common stock. As of April 2, 2026, there were 99,812,515 Class A shares and 23,970,359 Class B shares outstanding and entitled to vote.
All seven director nominees, including Talat Imran, Mir Imran, and the other board members listed, were elected to serve until the 2027 annual meeting or until successors are elected and qualified. Stockholders also ratified the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Class A shares entitled to vote: 99,812,515 shares
Class B shares entitled to vote: 23,970,359 shares
Votes for Talat Imran: 57,336,620 votes
+5 more
8 metrics
Class A shares entitled to vote
99,812,515 shares
Outstanding and entitled to vote as of April 2, 2026
Class B shares entitled to vote
23,970,359 shares
Outstanding and entitled to vote as of April 2, 2026
Votes for Talat Imran
57,336,620 votes
Director election at 2026 annual meeting
Votes for Mir Imran
56,592,898 votes
Director election at 2026 annual meeting
Votes for Dennis Ausiello, M.D.
57,356,662 votes
Director election at 2026 annual meeting
Auditor ratification votes for
77,019,828 votes
Ratification of CBIZ CPAs P.C. for fiscal 2026
Auditor ratification votes against
332,645 votes
Ratification of CBIZ CPAs P.C. for fiscal 2026
Auditor ratification abstentions
54,190 votes
Ratification of CBIZ CPAs P.C. for fiscal 2026
Key Terms
Emerging growth company, record date, broker non-votes, independent registered public accounting firm, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company Item 5.07 Submission of Matters to a Vote"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
record date financial
"As of April 2, 2026, the record date for the Annual Meeting"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
broker non-votes financial
"Talat Imran | 57,336,620 | 148,439 | 19,921,604"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm regulatory
"ratified the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Annual Meeting financial
"held its annual meeting of stockholders (“Annual Meeting”)"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Rani Therapeutics (RANI) stockholders vote on at the 2026 annual meeting?
Stockholders elected seven directors and ratified CBIZ CPAs P.C. as independent auditor for 2026. All proposals described in the proxy statement were approved based on the inspector of election’s report of voting results.
When was the Rani Therapeutics 2026 annual meeting held and what was the record date?
The annual meeting took place on May 28, 2026. The record date was April 2, 2026, when holders of 99,812,515 Class A and 23,970,359 Class B shares were entitled to vote at the meeting.
Which directors were elected at Rani Therapeutics’ 2026 annual meeting?
Stockholders elected Talat Imran, Mir Imran, Dennis Ausiello, M.D., Jean-Luc Butel, Vasudev Bailey, Ph.D., Abraham Bassan, and Lisa Rometty. Each will serve until the 2027 annual meeting or until a successor is duly elected and qualified.
How did Rani Therapeutics stockholders vote on the auditor ratification for 2026?
Stockholders ratified the appointment of CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026, with 77,019,828 votes for, 332,645 against, and 54,190 abstentions.
How many votes did key Rani Therapeutics director nominees receive?
For example, Talat Imran received 57,336,620 votes for and 148,439 withheld, while Mir Imran received 56,592,898 for and 892,161 withheld. Each nominee had 19,921,604 broker non-votes recorded in the results.
AI-generated analysis. How Rhea-AI works. Not financial advice.
